Robeco Institutional Asset Management B.V. Zai Lab LTD Transaction History
Robeco Institutional Asset Management B.V.
- $49.7 Billion
- Q3 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Zai Lab LTD stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 52,035 shares of ZLAB stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,035
Previous 52,035
-0.0%
Holding current value
$1.61 Million
Previous $901,000
39.4%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ZLAB
# of Institutions
116Shares Held
40.8MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$220 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$201 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$164 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$72 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$62.9 Million0.14% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.02B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...